Table 1 Characteristics and disease severity of study cohort of people with gout (n = 320)
N (%), unless specified otherwise | |
|---|---|
Demographics | |
Age, mean (SD) | 57.0 (13.4) |
Male sex | 166 (72%) |
Race/ethnicity1 | |
White | 179 (77%) |
Black or African American | 13 (6%) |
Asian | 24 (10%) |
American Indian or Alaskan Native | 1 (0.4%) |
Native Hawaiian or other Pacific Islander | 13 (6%) |
Other | 13 (6%) |
Hispanic ethnicity1 | 24 (10%) |
Gout: disease, flare*, treatment, and comorbidity characteristics | |
Gout duration, years, mean (SD)2 | 7.6 (10.8) |
Gout flares in the last month, mean (SD)3 | 1.5 (1.3) |
Gout flares in the last year, mean (SD)3 | 5.2 (6.1) |
Gout flares in the last month3 | |
None | 58 (20%) |
1 | 115 (40%) |
2 | 69 (24%) |
3 | 20 (6%) |
4 | 11 (3%) |
5 | 17 (5%) |
Gout flares in the last year3 | |
None | 45 (16%) |
1 | 51 (18%) |
2 | 36 (13%) |
3 | 37 (12%) |
4 | 13 (4%) |
5 | 19 (6%) |
≥ 6 | 85 (30%) |
Doctor prescribed allopurinol or febuxostat3 | 155 (54%) |
Days in the last month missed a dose of allopurinol or febuxostat, mean (SD)4 | 8.0 (12.3) |
Days in the last month missed a dose of allopurinol or febuxostat4 | |
0 | 72 (51%) |
1 | 6 (4%) |
2 | 8 (6%) |
3 | 9 (6%) |
4 | 3 (2%) |
5 | 4 (2%) |
≥ 6 | 39 (28%) |
Number of medical conditions diagnosed, including gout, mean (SD)5 | 2.8 (2.6) |
Number of medical conditions diagnosed, including gout 5 | |
1 | 97 (38%) |
2 | 50 (20%) |
3 | 52 (20%) |
4 | 21 (8%) |
≥ 5 | 35 (14%) |
How bad are the symptoms from your gout overall?6 | |
Very severe (as bad as it can be) | 58 (24%) |
Severe | 102 (42%) |
Moderate | 57 (24%) |
Mild | 17 (7%) |
No symptoms from my gout | 7 (3%) |